文献速递咽喉与嗓音

细胞孢菌素-B对声带成纤维细胞的作用

The effects of cytosporone-B, a novel antifibrotic agent, on vocal fold fibroblasts.
PubMed 文献 · Laryngoscope · 2018-10-16

该体外研究探讨了NR4A1激动剂细胞孢菌素-B(Csn-B)对TGF-β1刺激的人声带成纤维细胞纤维化表型的影响,发现Csn-B可显著下调TGF-β1诱导的COL1A1和ACTA2表达,并减少细胞收缩表型,提示其可能成为声带纤维化的治疗候选药物。

要点

  • Csn-B显著抑制TGF-β1诱导的COL1A1和ACTA2基因表达。
  • Csn-B减少TGF-β1介导的细胞收缩表型。
  • Csn-B对TGF-β/Smad信号通路相关基因无影响。

核心结论

  • NR4A1是声带纤维化的内源性抑制剂,Csn-B作为NR4A1激动剂可能成为声带纤维化的治疗候选药物。

研究设计与样本

  • 体外研究,使用人声带成纤维细胞,暴露于TGF-β1加或不加Csn-B。

主要发现

  • Csn-B对TGF-β/Smad信号通路相关基因无影响。

临床怎么用

  • Csn-B可能作为声带纤维化的潜在治疗药物,但需进一步体内研究验证。

局限性

  • 本研究为体外实验,结果需在体内模型中确认。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES/HYPOTHESIS: Our laboratory recently described NR4A1 as an endogenous inhibitor of TGF-β-induced vocal fold (VF) fibrosis. Our prior report described the temporal expression of NR4A1 during VF healing in vivo and the effects of NR4A1 knockdown on fibroplastic cell activities in vitro. Based on these findings, we hypothesized that cytosporone-B (Csn-B), an NR4A1 agonist, may hold significant therapeutic potential. STUDY DESIGN: In vitro. METHODS: Human VF fibroblasts were exposed to TGF-β1+/-Csn-B. Expression of genes related to fibrosis were quantified. In addition, contraction was assayed as a surrogate for the fibrotic phenotype in our cell line. RESULTS: TGF-B1 stimulated COL1A1 and ACTA2, as expected. Csn-B significantly downregulated TGF-β1-mediated upregulation of these genes (P = .009, P = .03, respectively). Csn-B had no effect on genes related to TGF-β/Smad signaling. Csn-B also decreased the TGF-β1-mediated contractile phenotype in our cells (P = .004). CONCLUSIONS: NR4A1 is an endogenous inhibitor of fibrosis in the vocal folds and Csn-B, as an NR4A1 agonist, may evolve as an ideal, therapeutic candidate for this challenging condition. LEVEL OF EVIDENCE: NA Laryngoscope, 128:E425-E428, 2018.

来源:Laryngoscope,查看原文。版权归原作者所有。

引用

  1. Hiwatashi N, Mukudai S, Bing R, et al. The effects of cytosporone-B, a novel antifibrotic agent, on vocal fold fibroblasts. Laryngoscope. 2018. PMID: 30325029. doi:10.1002/lary.27361

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。